French trial on contaminated blood products collapses
This article was originally published in Clinica
The trial of the former French prime minister and two government ministers on charges of manslaughter, relating to the delayed introduction of HIV screening of blood products in 1985, has collapsed because of "insufficient evidence".
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.